Therapy and clinical outcome of 18 V-form APL patients on Intergroup protocol 0129
UPN . | Induction Therapy . | CR . | Maintenance Arm . | Relapse . | CR Duration (Months) . | Status . | Survival (Months) . |
---|---|---|---|---|---|---|---|
C132 | DA | No | — | — | — | Dead | 19 |
C205 | DA | Yes3-150 | ATRA | — | — | Alive | 51 |
S448 | DA | Yes | Obs | Yes | 8 | Dead | 27 |
S444 | ATRA | Yes | ATRA | No | 40 | Alive | 42 |
E076 | ATRA | No | — | — | — | Dead | 35 |
C902 | ATRA | Yes | Obs | No | 46 | Alive | 48 |
E003 | ATRA3-151 | No | — | — | — | Dead | 27 |
E011 | DA | Yes | ATRA | Yes | 8 | Dead | 11 |
E801 | DA | Yes | ATRA | No | 48 | Alive | 49 |
E036 | DA | Yes | — | No | 13-152 | Alive | 67 |
E086 | DA3-153 | Yes | Obs | Yes | 16 | Alive | 52 |
S386 | DA | Yes | Obs | Yes | 28 | Dead | 35 |
E805 | DA | No | — | — | — | Dead | 14 |
C179 | ATRA | Yes | —3-6 | Yes | 48 | Alive | 60 |
E027 | DA | No | — | — | — | Dead | 3 |
E091 | DA | Yes | Obs | No | 50 | Alive | 51 |
C183 | ATRA | Yes | ATRA | No | 5 | Alive | 7 |
E070 | ATRA | Yes | Obs | Yes | 10 | Dead | 13 |
UPN . | Induction Therapy . | CR . | Maintenance Arm . | Relapse . | CR Duration (Months) . | Status . | Survival (Months) . |
---|---|---|---|---|---|---|---|
C132 | DA | No | — | — | — | Dead | 19 |
C205 | DA | Yes3-150 | ATRA | — | — | Alive | 51 |
S448 | DA | Yes | Obs | Yes | 8 | Dead | 27 |
S444 | ATRA | Yes | ATRA | No | 40 | Alive | 42 |
E076 | ATRA | No | — | — | — | Dead | 35 |
C902 | ATRA | Yes | Obs | No | 46 | Alive | 48 |
E003 | ATRA3-151 | No | — | — | — | Dead | 27 |
E011 | DA | Yes | ATRA | Yes | 8 | Dead | 11 |
E801 | DA | Yes | ATRA | No | 48 | Alive | 49 |
E036 | DA | Yes | — | No | 13-152 | Alive | 67 |
E086 | DA3-153 | Yes | Obs | Yes | 16 | Alive | 52 |
S386 | DA | Yes | Obs | Yes | 28 | Dead | 35 |
E805 | DA | No | — | — | — | Dead | 14 |
C179 | ATRA | Yes | —3-6 | Yes | 48 | Alive | 60 |
E027 | DA | No | — | — | — | Dead | 3 |
E091 | DA | Yes | Obs | No | 50 | Alive | 51 |
C183 | ATRA | Yes | ATRA | No | 5 | Alive | 7 |
E070 | ATRA | Yes | Obs | Yes | 10 | Dead | 13 |
UPN indicates unique patient number; CR, complete remission; DA, daunorubicin and Ara-C; ATRA, all-trans retinoic acid; Obs, observation.
Because the CR for case C205 was undocumented, no CR duration is available, and this case is not included in the disease-free survival plot shown in Figure 3.
No CR after ATRA for 42 days; crossed over to DA and achieved CR.
Taken off protocol and received alternative consolidation. Censored at day 28 for CR duration.
Randomized to ATRA but received DA instead due to refractory leukocytosis.
Not registered to the maintenance arm.